Latest news with #Paysign
Yahoo
a day ago
- Business
- Yahoo
Paysign price target raised to $8 from $7 at DA Davidson
DA Davidson analyst Peter Heckmann raised the firm's price target on Paysign (PAYS) to $8 from $7 and keeps a Buy rating on the shares. Last week, Paysign announced the company had been awarded 132 established plasma donation centers through an expansion of a relationship with a major plasma collection company, and the firm believes this will increase the company's total plasma locations to 613 centers, a 27% increase over the 484 locations served at the end of Q1, the analyst tells investors in a research note. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on PAYS: Disclaimer & DisclosureReport an Issue PaySign's Strong Growth Potential and Strategic Positioning in Healthcare: A Buy Rating by Gary Prestopino Paysign participates in a conference call with DA Davidson PaySign's Strong Growth Potential and Strategic Positioning Earns Buy Rating from Analyst Paysign awarded 132 plasma donation centers Paysign price target raised to $6-$7 range from $5 at Barrington
Business Wire
4 days ago
- Business
- Business Wire
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025. We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. Share The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign's operational agility, platform scalability and executional discipline. 'Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team,' said Mark Newcomer, President and CEO of Paysign. 'We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign's forward momentum.' This achievement reinforces Paysign's strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company's continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit
Yahoo
4 days ago
- Business
- Yahoo
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
HENDERSON, Nev., June 11, 2025--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025. The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign's operational agility, platform scalability and executional discipline. "Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team," said Mark Newcomer, President and CEO of Paysign. "We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign's forward momentum." This achievement reinforces Paysign's strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company's continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit View source version on Contacts Investor Relations ir@ Media Relations Alicia Ches888.522.4850pr@
Yahoo
05-06-2025
- Business
- Yahoo
Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition
The Additions Significantly Increase the Company's U.S. Plasma Market Share HENDERSON, Nev., June 05, 2025--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has been awarded 132 established plasma donation centers through an expansion of its long-standing relationship with a major plasma collection company. Transition of the centers from the incumbent provider is underway, with 123 centers expected to be live by the end of the second quarter of 2025 and the remaining nine slated for transition during the third quarter of 2025. "The addition of these centers underscores the strengths of the Paysign donor compensation platform and our ongoing investment in the plasma industry, as well as the hard work and dedication of the entire Paysign team," said Mark Newcomer, President and CEO of Paysign. "This expansion once again reflects the confidence our clients, partners and customers have in our ability to deliver reliable, scalable and innovative solutions. It also reaffirms our position as a trusted partner to the plasma industry, where maximizing the donor experience is paramount." With the addition of these centers, Paysign will be providing donor compensation programs to more than 615 plasma centers across 18 plasma collection companies, increasing the number of centers the company supports by 27% and bringing its U.S. market share to approximately 50%. The additional centers will drive immediate revenue growth for Paysign's plasma business. Following onboarding, the centers are expected to reach approximately 80% of Paysign's average revenue per center within the first few weeks and reach full revenue contribution by the end of the first quarter of 2026. Notably, the company does not anticipate a corresponding increase in Selling, General and Administrative (SG&A) expenses related to these new centers, highlighting the operating leverage inherent in its business model. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit View source version on Contacts Investor Relationsir@ Media RelationsAlicia Ches888.522.4850pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
05-06-2025
- Business
- Business Wire
Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has been awarded 132 established plasma donation centers through an expansion of its long-standing relationship with a major plasma collection company. Transition of the centers from the incumbent provider is underway, with 123 centers expected to be live by the end of the second quarter of 2025 and the remaining nine slated for transition during the third quarter of 2025. The addition of these centers underscores the strengths of the Paysign donor compensation platform and our ongoing investment in the plasma industry. 'The addition of these centers underscores the strengths of the Paysign donor compensation platform and our ongoing investment in the plasma industry, as well as the hard work and dedication of the entire Paysign team,' said Mark Newcomer, President and CEO of Paysign. 'This expansion once again reflects the confidence our clients, partners and customers have in our ability to deliver reliable, scalable and innovative solutions. It also reaffirms our position as a trusted partner to the plasma industry, where maximizing the donor experience is paramount.' With the addition of these centers, Paysign will be providing donor compensation programs to more than 615 plasma centers across 18 plasma collection companies, increasing the number of centers the company supports by 27% and bringing its U.S. market share to approximately 50%. The additional centers will drive immediate revenue growth for Paysign's plasma business. Following onboarding, the centers are expected to reach approximately 80% of Paysign's average revenue per center within the first few weeks and reach full revenue contribution by the end of the first quarter of 2026. Notably, the company does not anticipate a corresponding increase in Selling, General and Administrative (SG&A) expenses related to these new centers, highlighting the operating leverage inherent in its business model. Forward-Looking Statements Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit
